Trimetrexate glucuronate
- CAS NO.:82952-64-5
- Empirical Formula: C25H33N5O10
- Molecular Weight: 563.56
- MDL number: MFCD01725300
- SAFETY DATA SHEET (SDS)
- Update Date: 2024-07-02 08:55:14
What is Trimetrexate glucuronate?
Description
Trimetrexate glucuronate is a nonclassical antifolate introduced in the U.S.A. and Canada as second-line therapy for the treatment of Pneumocystis carinii pneumonia (PCP) and toxoplasmosis in AIDS patients who are refractory or intolerant to co-trimoxazole therapy. Trimetrexate glucuronate is reportedly to be in clinical trials for the treatment of several types of cancer including colorectal, gastric, pancreas, prostate, bladder, lung, breast, head, and neck cancers. It is also in early clinical trials for topical use in treating psoriasis and as an oral drug to treat rheumatoid arthritis. The mechanism of action of trimetrexate glucuronate is via inhibition of the enzyme dihydrofolate reductase which mediates the reduction of dihydrofolate to tetrahydrofolic acid and results in disruption of DNA, RNA and protein synthesis, with consequent cell death. Due to its toxicity to bone marrow and the GI tract, trimetrexate glucuronate must be concurrently administered with leucovorin as a rescue agent.
Originator
Warner-Lambert (U.S.A.)
The Uses of Trimetrexate glucuronate
Antineoplastic.
The Uses of Trimetrexate glucuronate
CI 898 Glucuronate is a dihydrofolate reductase (DHFR) inhibitor.
Manufacturing Process
A mixture of 2,4-diamino-5-methyl-6-[(3,4,5- trimethoxyanilino)methyl]quinazoline (1.0 g) and glucuronic acid (0.7 g) in methanol (65 ml) is heated to dissolve the solid. The solution is cooled to 10°C and filtered to remove a small amount of solid. The filtrate is heated to reflux and ethyl acetate is added to the cloud point. The warm solution is filtered then slowly cooled. The solid that forms is collected, washed first with ethylacetate, then with ether and dried in vacuo at 60°C to give the 4- diamino-5-methyl-6-[(3,4,5-trimethoxyanilino)methyl]quinazoline D_x0002_glucuronate as a yellow powder with no definite melting point.
brand name
Neutrexin (MedImmune).
Therapeutic Function
Antineoplastic
Biological Activity
Potent lipophilic inhibitor of dihydrofolate reductase (DHFR) that displays antineoplastic and antiprotozoal properties. Inhibits protozoal, bacterial and human DHFR with IC 50 values of 1.4, 6.1 and 3.2 nM respectively. Affects G 1 /S phase cell cycle progression.
Properties of Trimetrexate glucuronate
storage temp. | Store at -20°C |
form | Solid |
color | Off-white to light yellow |
Safety information for Trimetrexate glucuronate
Computed Descriptors for Trimetrexate glucuronate
New Products
Tubulysin M 2,2-diethoxyethanethioamide Tubulysin C (2S,4R)-4-amino-2-methyl-5-phenylpentanoic acid hydrochloride Tubulysin G Potassium HMDS (1.0 M in THF) 3-Aminocyclobutanone hydrochloride 4,4-DIFLUOROCYCLOHEXANAMINE 3-N-BOC-(S)-AMINO BUTYRONITRILE 1-(1,1-Difluoroethyl)-2-fluorobenzene Isoxazole, 3-[[[5-(difluoromethoxy)-1-methyl-3-(trifluoromethyl)-1H-pyrazol-4-yl]methyl]thio]-4,5-dihydro-5,5-dimethyl- 4-(Benzyloxy)-3-bromophenylacetic Acid Fuel shell (1R,2S)-2-(3,4-Difluorophenyl)cyclopropanamine 2-(1-(Mercaptomethyl) cyclopropyl) acetonitrile 2-[2-[3(S)-3[2-(7-chloro-2-quinolinyl) ethenyl] phenyl-3- hydroxyl propyl] phenyl]-2-propanol Imeglimin Hydrochloride IH 2-[[(3aR,4S,6R,6aS)-6-Aminotetrahydro-2,2-dimethyl-4H-cyclopenta-1,3-dioxol-4-yl]oxy]ethanol ethanedioate Magnesium Trisilicate Latanoprostene Bunod Lubiprostone Flame Retardant Zinc Borate (R)-(3-(3-fluoro-4- thiomorpholinophenyl)-2- oxooxazolidin-4-yl) methyl methanesulfonate methyl 3-fluoro-4- thiomorpholino phenylcarbamateRelated products of tetrahydrofuran
You may like
-
(R)-(3-(3-fluoro-4- thiomorpholinophenyl)-2- oxooxazolidin-4-yl) methyl methanesulfonateView Details
2416850-45-6 -
methyl 3-fluoro-4- thiomorpholino phenylcarbamateView Details
2760359-22-4 -
Fuel shell 98%View Details
-
4,6-dichloro-2-propylthiopyrimidine-5-amine 145783-15-9 98%View Details
145783-15-9 -
Hydrogen Gas 98%View Details
-
151767-02-1 Montelukast Sodium IP/USP 98%View Details
151767-02-1 -
Valacyclovir Hydrochloride IH 98%View Details
124832-27-5 -
2-[2-[3(S)-3[2-(7-chloro-2-quinolinyl) ethenyl] phenyl-3- hydroxyl propyl] phenyl]-2-propanol 98%View Details
142569-70-8